GB1028205A - Improvements in or relating to medicinal compositions and method for relieving cough - Google Patents

Improvements in or relating to medicinal compositions and method for relieving cough

Info

Publication number
GB1028205A
GB1028205A GB31047/63A GB3104763A GB1028205A GB 1028205 A GB1028205 A GB 1028205A GB 31047/63 A GB31047/63 A GB 31047/63A GB 3104763 A GB3104763 A GB 3104763A GB 1028205 A GB1028205 A GB 1028205A
Authority
GB
United Kingdom
Prior art keywords
amino
methyl
amine
relating
heptane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31047/63A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB1028205A publication Critical patent/GB1028205A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An inhalant composition comprises as the essential active ingredient 2-amino-6-methyl heptane. It may be used in admixture with a vaso-constrictor amine, e.g. 1-cyclohexyl-2 methylamino propane, 1-cyclopentyl-2-aminopropane, 2-amino-4-methyl hexane, N-methyl phenyl tertiary butylamine, 2-aminoheptane or 1-1-phenyl2-methylaminopropane. The ratio of 2-amino6-methyl heptane to vasoconstrictor amine may range from 1 : 1 to 9 : 1. An inert liquid vehicle, e.g. dibutyl phthalate or benzyl salicylate, may be used. Compounds which reduce the vapour pressures of the specified amenes, e.g. alcohols, glycols, and essential oils, may also be incorporated. Flavouring agents, e.g. menthol or oil of lavender, may also be added. The amines may be treated with carbon dioxide in the presence or absence of water to form carbamates or carbonates. A vapor dosage of 0.25 mg.-1.5 mg. of 2-amino-6-methylheptane may be administered intranasally from 1 to 8 times per day using conventional pocket inhalers.
GB31047/63A 1962-08-23 1963-08-06 Improvements in or relating to medicinal compositions and method for relieving cough Expired GB1028205A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US218867A US3156614A (en) 1962-08-23 1962-08-23 Medicinal compositions and method for relieving cough

Publications (1)

Publication Number Publication Date
GB1028205A true GB1028205A (en) 1966-05-04

Family

ID=22816805

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31047/63A Expired GB1028205A (en) 1962-08-23 1963-08-06 Improvements in or relating to medicinal compositions and method for relieving cough

Country Status (3)

Country Link
US (1) US3156614A (en)
FR (1) FR2944M (en)
GB (1) GB1028205A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL299042A (en) * 1962-10-10
WO2010019255A1 (en) * 2008-08-13 2010-02-18 Virun, Inc. Compositions containing aminoalkanes and aminoalkane derivatives
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
WO2015200049A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
CA2986593A1 (en) * 2015-05-21 2016-11-24 Island Breeze Systems Ca, Llc Propellant based metered dose inhaler and food applicators and applicators
US11806645B1 (en) 2019-05-07 2023-11-07 Cannaceutical Extractions LLC Methods of producing CBD/THC oils

Also Published As

Publication number Publication date
FR2944M (en) 1964-11-23
US3156614A (en) 1964-11-10

Similar Documents

Publication Publication Date Title
DE69208660T2 (en) FLUORINE CHLORINE HYDROGEN-FREE AEROSOL FORMULATIONS
AR030209A1 (en) USE OF NEUROTOXINS IN THE TREATMENT OF PAIN IN MAMMALS
ES2091441T3 (en) PHARMACEUTICAL COMPOSITION.
ATE216575T1 (en) PROpellant gas mixture for an aerosol preparation
LU90366I2 (en) Nasonex
DK165440C (en) PHARMACEUTICAL PREPARATIONS FOR TOPICAL USE CONTAINING PROPYLENGYLYCOL AND / OR POLYETHYLENGYLYCOL AND URINENTS AS ACTIVE MAIN COMPONENTS
MX9301129A (en) NEW CYCLOSPORINS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2178048T3 (en) USE OF RIFAXIMINE AS A MEDICINAL PRODUCT FOR THE TREATMENT OF DIARRHEA BY CRYPTOSPORIDIOSIS.
ES2179996T3 (en) VINYL-PIRROLIDINONE CEPHALOSPORINS WITH BASIC SUBSTITUTES.
AR006401A1 (en) PIRROLOPYROLONE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AND IN THERAPY, PROCESSES FOR ITS PREPARATION AND INTERMEDIARY COMPOUNDS FOR SUCH PROCESSES.
GB1028205A (en) Improvements in or relating to medicinal compositions and method for relieving cough
HUT64232A (en) Process for the production of the medical agent by the extraction from tanacetum parthenium and for the production of medical prepartives containing it
AR007240A1 (en) ANALOGS OF VITAMIN D3 FLUORATED, MIXTURES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE TO DEVELOP A PHARMACEUTICAL COMPOSITION
ES507810A0 (en) PROCEDURE FOR HYDROFORMILAR OLEPHINICALLY UNSATURATED COMPOUNDS.
UA42719C2 (en) Compositions and methods for the treatment of immunomediated inflammatory disorders
JPS5296729A (en) Mixed vaccin for cyanomycosis
ATE8880T1 (en) NEW CARBAMATS, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
JPS5753492A (en) Novel propane diol derivative
GB701186A (en) Production of a smoke screen for protecting vegetation against frost
TH13252EX (en) Material: N-Oxide, Enanthiomer And its mixtures and used
GB949400A (en) Poliomyelitis vaccines
FR2474863B1 (en)
GB908332A (en) Non-pungent compositions comprising 1-cyclopentyl-2-aminopropane
NL6811874A (en) Aerosol compsns contng trialkyl borates for treatment - of skin infections
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis